S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
S&P 500   3,957.63
DOW   33,852.53
QQQ   280.57
Three Reasons It’s Time To Get Bullish On Organigram
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
The AP Interview: IMF head urges China to end mass lockdowns
Survivor of Virginia Walmart mass shooting files $50M suit
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Can I Apply for Supplemental Security Income Online?
US stocks edge lower in unsteady trading, oil prices rise
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
Walmart employee who survived mass shooting at store in Virginia has filed a $50 million lawsuit against the company
TSE:EXE

Extendicare - EXE Stock Forecast, Price & News

C$6.75
+0.14 (+2.12%)
(As of 11/29/2022 12:00 AM ET)
Add
Compare
Today's Range
C$6.65
C$6.83
50-Day Range
C$6.49
C$7.23
52-Week Range
C$6.47
C$8.00
Volume
124,092 shs
Average Volume
163,545 shs
Market Capitalization
C$566.59 million
P/E Ratio
84.38
Dividend Yield
7.22%
Price Target
C$7.50
EXE stock logo

About Extendicare (TSE:EXE) Stock

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.

Receive EXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.

EXE Stock News Headlines

FY2022 EPS Estimates for Extendicare Inc. (TSE:EXE) Cut by Analyst
What Is Extendicare Inc.'s (TSE:EXE) Share Price Doing?
See More Headlines
Receive EXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter.

EXE Company Calendar

Ex-Dividend for 10/17 Dividend
9/28/2022
Dividend Payable
10/17/2022
Ex-Dividend for 11/15 Dividend
10/28/2022
Dividend Payable
11/15/2022
Today
11/30/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Long - Term Care Facilities
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
23,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$7.50
High Stock Price Forecast
C$8.00
Low Stock Price Forecast
C$7.00
Forecasted Upside/Downside
+11.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.27 billion
Cash Flow
C$2.13 per share
Book Value
C$1.49 per share

Miscellaneous

Free Float
N/A
Market Cap
C$566.59 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Michael R. Guerriere M.D. (Age 58)
    MBA, CEO, Pres & Director
    Comp: $1.13M
  • Mr. David E. Bacon
    Sr. VP & CFO
  • Mr. John Toffoletto
    Sr. VP, Chief Legal Officer & Corp. Sec.
  • Ms. Leslie Sarauer (Age 60)
    Sr. VP & Chief HR Officer
    Comp: $567.15k
  • Mr. Bruce Wienberg
    Sr. VP of Resident Care
  • Mr. Ali Mohammad Mir
    VP, ParaMed Operations
  • Mr. Steve Paraskevopoulos
    Sr. VP of ParaMed & CTO
  • Ms. Jillian E. Fountain
    VP of Investor Relations
  • Ms. Lisa Pearson
    VP of Public Affairs
  • Ms. Elaine E. Everson
    VP of Corp. Devel.













EXE Stock - Frequently Asked Questions

Should I buy or sell Extendicare stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EXE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXE, but not buy additional shares or sell existing shares.
View EXE analyst ratings
or view top-rated stocks.

What is Extendicare's stock price forecast for 2023?

3 brokerages have issued twelve-month target prices for Extendicare's shares. Their EXE share price forecasts range from C$7.00 to C$8.00. On average, they anticipate the company's stock price to reach C$7.50 in the next year. This suggests a possible upside of 11.1% from the stock's current price.
View analysts price targets for EXE
or view top-rated stocks among Wall Street analysts.

How have EXE shares performed in 2022?

Extendicare's stock was trading at C$7.30 on January 1st, 2022. Since then, EXE stock has decreased by 7.5% and is now trading at C$6.75.
View the best growth stocks for 2022 here
.

When is Extendicare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our EXE earnings forecast
.

How often does Extendicare pay dividends? What is the dividend yield for Extendicare?

Extendicare announced a monthly dividend on Friday, October 28th. Stockholders of record on Tuesday, November 15th will be given a dividend of 0.04 per share on Tuesday, November 15th. This represents a $0.48 dividend on an annualized basis and a yield of 7.11%. The ex-dividend date of this dividend is Friday, October 28th.
Read our dividend analysis for EXE
.

Is Extendicare a good dividend stock?

Extendicare (TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 7.22%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 600.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for EXE.

What other stocks do shareholders of Extendicare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA).

What is Extendicare's stock symbol?

Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE."

How do I buy shares of Extendicare?

Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Extendicare's stock price today?

One share of EXE stock can currently be purchased for approximately C$6.75.

How much money does Extendicare make?

Extendicare (TSE:EXE) has a market capitalization of C$566.59 million and generates C$1.27 billion in revenue each year.

How many employees does Extendicare have?

The company employs 23,000 workers across the globe.

How can I contact Extendicare?

The official website for the company is www.extendicare.com. The company can be reached via phone at 905-470-4000.

This page (TSE:EXE) was last updated on 11/30/2022 by MarketBeat.com Staff